Drug
7-hydroxystaurosporine clinical trials
Also written UCN-01.
- studies test it
- 12
- open now
- 0
- in phase 3
- 0
- first study started
- 1995
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2002 (3)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1998 | 1 |
| 1999 | 1 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 12
National Cancer Institute (NCI) (9) · M.D. Anderson Cancer Center (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · University of California, San Francisco (1)
Often tested with
Tested in the same studies.
Topotecan (1) · Irinotecan (1) · Perifosine (1) · Carboplatin (1) · Gemcitabine (1) · Cytarabine (1) · Cisplatin (1)
Studies
Open first, then newest update. How each study uses 7-hydroxystaurosporine is read from its arms, and is right about nine times in ten.
Testing it · 12
- 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung CancerCompletedPhase 2National Cancer Institute (NCI)NCT00098956Written as 7-hydroxystaurosporine
- UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell LymphomasTerminatedPhase 2National Cancer Institute (NCI)NCT00082017Written as UCN-01 (7-hydroxystaurosporine)
- A Phase II Study of UCN-01 in Metastatic MelanomaTerminatedPhase 2National Cancer Institute (NCI)NCT00072189Written as 7-hydroxystaurosporine
- UCN-01 in Treating Patients With Advanced or Metastatic Kidney CancerStatus unknownPhase 2University of California, San FranciscoNCT00030888Written as 7-hydroxystaurosporine
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedPhase 1National Cancer Institute (NCI)NCT00031681Written as 7-hydroxystaurosporine
- 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic SyndromesCompletedPhase 1National Cancer Institute (NCI)NCT00301938Written as 7-hydroxystaurosporine
- 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid TumorsTerminatedPhase 1National Cancer Institute (NCI)NCT00012194Written as 7-hydroxystaurosporine
- UCN-01 and Carboplatin in Treating Patients With Advanced Solid TumorsCompletedPhase 1National Cancer Institute (NCI)NCT00036777Written as 7-hydroxystaurosporine
- UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerCompletedPhase 1National Cancer Institute (NCI)NCT00039403Written as 7-hydroxystaurosporine
- Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedPhase 1M.D. Anderson Cancer CenterNCT00004263Written as 7-hydroxystaurosporine (UCN-01)
- UCN-01 in Treating Patients With Advanced CancerCompletedPhase 1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT00003289Written as 7-hydroxystaurosporine
- A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory NeoplasmsCompletedPhase 1National Cancer Institute (NCI)NCT00001444Written as 7-hydroxystaurosporine (UCN-01)
Given in every arm · 1 — 7-hydroxystaurosporine is usual care beside what is tested
Codes
What other systems call 7-hydroxystaurosporine · ClinicalTrials.gg INT003363
- MeSH (NLM) C0548527-hydroxystaurosporineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7BU5H4V94A7-HYDROXYSTAUROSPORINEConfirmed FDA, NLM, Wikidata
- Wikidata Q270740357-hydroxystaurosporineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C12717-HydroxystaurosporineOne source FDA
- DrugBank DB01933One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C054852 | 7-hydroxystaurosporine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7BU5H4V94A | 7-HYDROXYSTAUROSPORINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27074035 | 7-hydroxystaurosporine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1271 | 7-Hydroxystaurosporine | One source FDA |
| DrugBank | DB01933 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.